{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:01:16Z","timestamp":1793937676042,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Research and Development Plan of Shaanxi Province, China","award":["2021SF-298"],"award-info":[{"award-number":["2021SF-298"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Glioblastoma multiforme (GBM) is one of the most common primary malignant brain tumors. Yi Qi Qu Yu Jie Du Fang (YYQQJDF) is a traditional Chinese medicine (TCM) prescription for GBM. The present study aimed to use a network pharmacology method to analyze the underlying mechanism of YQQYJDF in treating GBM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>GBM sample data, active ingredients and potential targets of YQQYJDF were obtained from databases. R language was used to screen differentially expressed genes (DEGs) between GBM tissues and normal tissues, and to perform enrichment analysis and weighted gene coexpression network analysis (WGCNA). The Search Tool for the Retrieval of Interacting Genes\/Proteins (STRING) database was used to perform a protein\u2012protein interaction (PPI) analysis. A Venn diagram was used to obtain the core target genes of YQQYJDF for GBM treatment. Molecular docking was used to verify the binding between the active ingredient molecules and the proteins corresponding to the core target genes. Cell proliferation assays and invasion assays were used to verify the effect of active ingredients on the proliferation and invasion of glioma cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 73 potential targets of YQQYJDF in the treatment of GBM were obtained. Enrichment analyses showed that the biological processes and molecular functions involved in these target genes were related to the activation of the G protein-coupled receptor (GPCR) signaling pathway and the regulation of hypoxia. The neuroactive ligand\u2012receptor pathway, the cellular senescence pathway, the calcium signaling pathway, the cell cycle pathway and the p53 signaling pathway might play important roles. Combining the results of WGCNA and PPI analysis, five core target genes and their corresponding four core active ingredients were screened. Molecular docking indicated that the core active ingredient molecules and the proteins corresponding to the core target genes had strong binding affinities. Cell proliferation and invasion assays showed that the core active ingredients of YQQYJDF significantly inhibited the proliferation and invasion of glioma cells (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The present study predicted the possible active ingredients and targets of YQQYJDF in treating GBM, and analyzed its possible mechanism. These results may provide a basis and ideas for further research.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12906-023-04174-7","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T07:02:57Z","timestamp":1695798177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Network pharmacology -based study on the mechanism of traditional Chinese medicine in the treatment of glioblastoma multiforme"],"prefix":"10.1186","volume":"23","author":[{"given":"Chen","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"issue":"3","key":"4174_CR1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/pr.117.014944","volume":"70","author":"A Shergalis","year":"2018","unstructured":"Shergalis A, Bankhead A 3rd, Luesakul U, Muangsin N, Neamati N. Current challenges and opportunities in treating glioblastoma. Pharmacol Rev. 2018;70(3):412\u201345.","journal-title":"Pharmacol Rev"},{"issue":"17","key":"4174_CR2","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.2174\/1871520620666200804104243","volume":"20","author":"F Zhang","year":"2020","unstructured":"Zhang F, Lv H, Zhang X. Erinacerins, novel glioma inhibitors from hericium erinaceus, induce apoptosis of u87 cells through Bax\/Capase-2 pathway. Anticancer Agents Med Chem. 2020;20(17):2082\u20138.","journal-title":"Anticancer Agents Med Chem"},{"key":"4174_CR3","first-page":"2198722","volume":"2022","author":"T Li","year":"2022","unstructured":"Li T, Xiao Y, Wang Z, Xiao H, Liu H. The mechanism study of common flavonoids on antiglioma based on network pharmacology and molecular docking. Evid Based Complement Alternat Med. 2022;2022:2198722.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"04","key":"4174_CR4","first-page":"71","volume":"34","author":"H Wang","year":"2021","unstructured":"Wang H, Luo W, Ma ST, Zhao XP, Fan XX, Wang K, Yang YF. Medication rules of TCM in treating glioma based on data mining. W J Tradit Chinese Med. 2021;34(04):71\u20134.","journal-title":"W J Tradit Chinese Med"},{"issue":"11","key":"4174_CR5","first-page":"4943","volume":"32","author":"L Wang","year":"2017","unstructured":"Wang L, Wang S, Yang T, Tong YP, Kang YZ, Wang AW, Wan JL, Zhao TY, Cheng CC, Fan YP. Analysis of TCM syndromes and medication characteristics of 32 patients with brainstem glioma. Chin J Tradit Chinese Med Pharm. 2017;32(11):4943\u20135.","journal-title":"Chin J Tradit Chinese Med Pharm"},{"key":"4174_CR6","first-page":"4139200","volume":"2022","author":"S Zhou","year":"2022","unstructured":"Zhou S, Bi J, Zhao W, Zhao J, Wan H, Wang S. Study on the mechanism of fentanyl in pain treatment based on network pharmacology. J Healthc Eng. 2022;2022:4139200.","journal-title":"J Healthc Eng"},{"key":"4174_CR7","doi-asserted-by":"crossref","first-page":"3900636","DOI":"10.1155\/2022\/3900636","volume":"2022","author":"L Zheng","year":"2022","unstructured":"Zheng L, Jiang H, Li R, Song L, Chen R, Dong H. The pharmacological mechanisms of xiaochaihutang in treating breast cancer based on network pharmacology. Contrast Media Mol Imaging. 2022;2022:3900636.","journal-title":"Contrast Media Mol Imaging"},{"key":"4174_CR8","first-page":"8141443","volume":"2022","author":"M Zou","year":"2022","unstructured":"Zou M, Zhu Y. Exploring the molecular mechanism of Tong Xie Yao Fang in treating ulcerative colitis using network pharmacology and molecular docking. Evid Based Complement Alternat Med. 2022;2022:8141443.","journal-title":"Evid Based Complement Alternat Med"},{"key":"4174_CR9","unstructured":"The Cancer Genome Atlas Program. National Cancer Institute at the National Institutes of Health. 2022. https:\/\/www.cancer.gov\/about-nci\/organization\/ccg\/research\/structural-genomics\/tcga. Accessed 22 Nov 2022."},{"key":"4174_CR10","unstructured":"Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform. Lab of Systems Pharmacology, China. 2022. https:\/\/old.tcmsp-e.com\/tcmsp.php. Accessed 28 Nov 2022."},{"key":"4174_CR11","unstructured":"Traditional Chinese Medicine database. Laboratory of computational and systems biology, China Medical University. 2022. http:\/\/tcm.cmu.edu.tw\/. Accessed 28 Nov 2022."},{"key":"4174_CR12","unstructured":"Venny 2.1. https:\/\/bioinfogp.cnb.csic.es\/tools\/venny\/. Accessed 12 Dec 2022."},{"issue":"1","key":"4174_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"4174_CR14","unstructured":"STRING Database. 2022. https:\/\/string-db.org\/. Accessed 15 Dec 2022."},{"key":"4174_CR15","unstructured":"DrugBank Online. 2022. https:\/\/go.drugbank.com\/. Accessed 16 Dec 2022."},{"key":"4174_CR16","unstructured":"Protein Data Bank. Research collaboratory for structural bioinformatics. 2022. (https:\/\/www.rcsb.org\/). Accessed 17 Dec 2022."},{"issue":"7378","key":"4174_CR17","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1038\/480S82a","volume":"480","author":"F Cheung","year":"2011","unstructured":"Cheung F. TCM: made in China. Nature. 2011;480(7378):S82\u20133.","journal-title":"Nature"},{"key":"4174_CR18","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/erm.2018.3","volume":"20","author":"J Wang","year":"2018","unstructured":"Wang J, Wong YK, Liao F. What has traditional Chinese medicine delivered for modern medicine? Expert Rev Mol Med. 2018;20:e4.","journal-title":"Expert Rev Mol Med"},{"key":"4174_CR19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.fitote.2013.10.010","volume":"92","author":"Y Yang","year":"2014","unstructured":"Yang Y, Zhang Z, Li S, Ye X, Li X, He K. Synergy effects of herb extracts: pharmacokinetics and pharmacodynamic basis. Fitoterapia. 2014;92:133\u201347.","journal-title":"Fitoterapia"},{"key":"4174_CR20","doi-asserted-by":"crossref","first-page":"116565","DOI":"10.1016\/j.jep.2023.116565","volume":"314","author":"S Wu","year":"2023","unstructured":"Wu S, Sun Z, Guo Z, Li P, Mao Q, Tang Y, Chen H, Peng H, Wang S, Cao Y. The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines (BAST) in lung cancer progression-a comprehensive review. J Ethnopharmacol. 2023;314:116565.","journal-title":"J Ethnopharmacol"},{"key":"4174_CR21","doi-asserted-by":"crossref","first-page":"110142","DOI":"10.1016\/j.biopha.2020.110142","volume":"127","author":"F Yan","year":"2020","unstructured":"Yan F, Li F, Liu J, Ye S, Zhang Y, Jia J, Li H, Chen D, Mo X. The formulae and biologically active ingredients of Chinese herbal medicines for the treatment of atopic dermatitis. Biomed Pharmacother. 2020;127:110142.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4174_CR22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neures.2007.09.009","volume":"60","author":"J Stojic","year":"2008","unstructured":"Stojic J, Hagemann C, Haas S, Herbold C, Kuhnel S, Gerngras S, Roggendorf W, Roosen K, Vince GH. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res. 2008;60(1):40\u20139.","journal-title":"Neurosci Res"},{"issue":"1","key":"4174_CR23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prp.2010.10.003","volume":"207","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Zhan H, Xu W, Yuan Z, Lu P, Zhan L, Li Q. Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas. Pathol Res Pract. 2011;207(1):24\u20139.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"4174_CR24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11060-011-0549-x","volume":"104","author":"M Anand","year":"2011","unstructured":"Anand M, Van Meter TE, Fillmore HL. Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1) expression and invasion in glioma cell lines via the MAPK pathway. J Neurooncol. 2011;104(3):679\u201387.","journal-title":"J Neurooncol"},{"issue":"2","key":"4174_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-016-2168-z","volume":"129","author":"JN Tung","year":"2016","unstructured":"Tung JN, Ko CP, Yang SF, Cheng CW, Chen PN, Chang CY, Lin CL, Yang TF, Hsieh YH, Chen KC. Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo. J Neurooncol. 2016;129(2):201\u20139.","journal-title":"J Neurooncol"},{"issue":"1","key":"4174_CR26","first-page":"22","volume":"21","author":"C Liang","year":"2021","unstructured":"Liang C, Shangguan J, Yang L, Guo S. Downregulation of astrocyte elevated gene-1 expression inhibits the development of vasculogenic mimicry in gliomas. Exp Ther Med. 2021;21(1):22.","journal-title":"Exp Ther Med"},{"issue":"6","key":"4174_CR27","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.3892\/ol.2015.3120","volume":"9","author":"C Liang","year":"2015","unstructured":"Liang C, Yang L, Guo S. All-trans retinoic acid inhibits migration, invasion and proliferation, and promotes apoptosis in glioma cells in vitro. Oncol Lett. 2015;9(6):2833\u20138.","journal-title":"Oncol Lett"},{"issue":"2","key":"4174_CR28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11596-022-2517-4","volume":"42","author":"C Liang","year":"2022","unstructured":"Liang C, Yang L, Guo SW, Li RC. Downregulation of astrocyte elevated gene-1 expression combined with all-trans retinoic acid inhibits development of vasculogenic mimicry and angiogenesis in glioma. Curr Med Sci. 2022;42(2):397\u2013406.","journal-title":"Curr Med Sci"},{"issue":"3","key":"4174_CR29","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1007\/s13277-015-4230-4","volume":"37","author":"S Aroui","year":"2016","unstructured":"Aroui S, Najlaoui F, Chtourou Y, Meunier AC, Laajimi A, Kenani A, Fetoui H. Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway. Tumour Biol. 2016;37(3):3831\u20139.","journal-title":"Tumour Biol"},{"issue":"2","key":"4174_CR30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/or.2022.8462","volume":"49","author":"Y Gao","year":"2023","unstructured":"Gao Y, Ma X, Lu H, Xu P, Xu C. PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer. Oncol Rep. 2023;49(2):25.","journal-title":"Oncol Rep"},{"key":"4174_CR31","doi-asserted-by":"crossref","first-page":"602321","DOI":"10.3389\/fonc.2021.602321","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Fan H, Zhou X, Xiang Y, Liu Y. Prognostic significance and gene co-expression network of PLAU and PLAUR in gliomas. Front Oncol. 2021;11:602321.","journal-title":"Front Oncol"},{"issue":"4","key":"4174_CR32","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1002\/jcp.27209","volume":"234","author":"P Kaphle","year":"2019","unstructured":"Kaphle P, Li Y, Yao L. The mechanical and pharmacological regulation of glioblastoma cell migration in 3D matrices. J Cell Physiol. 2019;234(4):3948\u201360.","journal-title":"J Cell Physiol"},{"key":"4174_CR33","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3389\/fimmu.2017.01878","volume":"8","author":"M Silva","year":"2017","unstructured":"Silva M, Videira PA, Sackstein R. E-selectin ligands in the human mononuclear phagocyte system: implications for infection, inflammation, and immunotherapy. Front Immunol. 2017;8:1878.","journal-title":"Front Immunol"},{"key":"4174_CR34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12885-016-2366-2","volume":"16","author":"SA Kang","year":"2016","unstructured":"Kang SA, Blache CA, Bajana S, Hasan N, Kamal M, Morita Y, Gupta V, Tsolmon B, Suh KS, Gorenstein DG, et al. The effect of soluble E-selectin on tumor progression and metastasis. BMC Cancer. 2016;16:331.","journal-title":"BMC Cancer"},{"issue":"4","key":"4174_CR35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00280-016-3006-x","volume":"77","author":"P Borentain","year":"2016","unstructured":"Borentain P, Carmona S, Mathieu S, Jouve E, El-Battari A, Gerolami R. Inhibition of E-selectin expression on the surface of endothelial cells inhibits hepatocellular carcinoma growth by preventing tumor angiogenesis. Cancer Chemother Pharmacol. 2016;77(4):847\u201356.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"4174_CR36","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.17219\/acem\/126051","volume":"29","author":"Q Gu","year":"2020","unstructured":"Gu Q, Chen X, Zhou L, Liu X. Exosome EpCAM promotes the metastasis of glioma by targeting the CD44 signaling molecule on the surface of glioma cells. Adv Clin Exp Med. 2020;29(11):1277\u201382.","journal-title":"Adv Clin Exp Med"},{"key":"4174_CR37","doi-asserted-by":"crossref","unstructured":"Hao X, Zu M, Ning J, Zhou X, Gong Y, Han X, Meng Q, Li D, Ding S. Antitumor effect of luteolin proven by patient-derived organoids of gastric cancer. Phytother Res. 2023; Online ahead of print.","DOI":"10.1002\/ptr.7963"},{"issue":"5","key":"4174_CR38","first-page":"e39789","volume":"15","author":"H Aljohani","year":"2023","unstructured":"Aljohani H, Khodier AE, Al-Gayyar MM. Antitumor activity of luteolin against ehrlich solid carcinoma in rats via blocking Wnt\/beta-Catenin\/SMAD4 pathway. Cureus. 2023;15(5):e39789.","journal-title":"Cureus"},{"key":"4174_CR39","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2147\/OTT.S191158","volume":"12","author":"Y You","year":"2019","unstructured":"You Y, Wang R, Shao N, Zhi F, Yang Y. Luteolin suppresses tumor proliferation through inducing apoptosis and autophagy via MAPK activation in glioma. Onco Targets Ther. 2019;12:2383\u201396.","journal-title":"Onco Targets Ther"},{"issue":"11","key":"4174_CR40","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1080\/15476286.2018.1539607","volume":"15","author":"C Yi","year":"2018","unstructured":"Yi C, Li G, Ivanov DN, Wang Z, Velasco MX, Hernandez G, Kaundal S, Villarreal J, Gupta YK, Qiao M, et al. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells. Rna Biol. 2018;15(11):1420\u201332.","journal-title":"Rna Biol"},{"issue":"12","key":"4174_CR41","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.3390\/nu11122875","volume":"11","author":"P Fernandez-Palanca","year":"2019","unstructured":"Fernandez-Palanca P, Fondevila F, Mendez-Blanco C, Tunon MJ, Gonzalez-Gallego J, Mauriz JL. Antitumor effects of quercetin in hepatocarcinoma in vitro and in vivo models: a systematic review. Nutrients. 2019;11(12):2875.","journal-title":"Nutrients"},{"issue":"3","key":"4174_CR42","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1039\/C7FO01964E","volume":"9","author":"Q Wu","year":"2018","unstructured":"Wu Q, Needs PW, Lu Y, Kroon PA, Ren D, Yang X. Different antitumor effects of quercetin, quercetin-3\u2019-sulfate and quercetin-3-glucuronide in human breast cancer MCF-7 cells. Food Funct. 2018;9(3):1736\u201346.","journal-title":"Food Funct"},{"issue":"7","key":"4174_CR43","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2174\/1874467215666220211094136","volume":"15","author":"OR Tamtaji","year":"2022","unstructured":"Tamtaji OR, Razavi ZS, Razzaghi N, Aschner M, Barati E, Mirzaei H. Quercetin and glioma: which signaling pathways are involved? Curr Mol Pharmacol. 2022;15(7):962\u20138.","journal-title":"Curr Mol Pharmacol"},{"key":"4174_CR44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuint.2014.12.001","volume":"80","author":"HC Pan","year":"2015","unstructured":"Pan HC, Jiang Q, Yu Y, Mei JP, Cui YK, Zhao WJ. Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells. Neurochem Int. 2015;80:60\u201371.","journal-title":"Neurochem Int"},{"key":"4174_CR45","doi-asserted-by":"crossref","first-page":"963614","DOI":"10.3389\/fphar.2022.963614","volume":"13","author":"B Chen","year":"2022","unstructured":"Chen B, Li X, Wu L, Zhou D, Song Y, Zhang L, Wu Q, He Q, Wang G, Liu X, et al. Quercetin suppresses human glioblastoma migration and invasion via GSK3beta\/beta-catenin\/ZEB1 signaling pathway. Front Pharmacol. 2022;13:963614.","journal-title":"Front Pharmacol"},{"issue":"6","key":"4174_CR46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/10837450.2020.1740933","volume":"25","author":"M Ersoz","year":"2020","unstructured":"Ersoz M, Erdemir A, Derman S, Arasoglu T, Mansuroglu B. Quercetin-loaded nanoparticles enhance cytotoxicity and antioxidant activity on C6 glioma cells. Pharm Dev Technol. 2020;25(6):757\u201366.","journal-title":"Pharm Dev Technol"},{"issue":"5","key":"4174_CR47","doi-asserted-by":"crossref","first-page":"e0197563","DOI":"10.1371\/journal.pone.0197563","volume":"13","author":"J Wang","year":"2018","unstructured":"Wang J, Fang X, Ge L, Cao F, Zhao L, Wang Z, Xiao W. Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol. PLoS One. 2018;13(5):e0197563.","journal-title":"PLoS One"},{"key":"4174_CR48","doi-asserted-by":"crossref","first-page":"614419","DOI":"10.3389\/fbioe.2020.614419","volume":"8","author":"S Chen","year":"2020","unstructured":"Chen S, Ma J, Yang L, Teng M, Lai ZQ, Chen X, He J. Anti-glioblastoma activity of kaempferol via programmed cell death induction: involvement of autophagy and pyroptosis. Front Bioeng Biotechnol. 2020;8:614419.","journal-title":"Front Bioeng Biotechnol"},{"key":"4174_CR49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cbi.2015.07.014","volume":"242","author":"BL Santos","year":"2015","unstructured":"Santos BL, Oliveira MN, Coelho PL, Pitanga BP, da Silva AB, Adelita T, Silva VD, Costa Mde F, El-Bacha RS, Tardy M, et al. Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, migration, and by regulating extracellular matrix proteins and metalloproteinases expression. Chem Biol Interact. 2015;242:123\u201338.","journal-title":"Chem Biol Interact"},{"issue":"9","key":"4174_CR50","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1158\/1535-7163.MCT-06-0788","volume":"6","author":"V Sharma","year":"2007","unstructured":"Sharma V, Joseph C, Ghosh S, Agarwal A, Mishra MK, Sen E. Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther. 2007;6(9):2544\u201353.","journal-title":"Mol Cancer Ther"},{"key":"4174_CR51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.plipres.2017.06.002","volume":"67","author":"A Ferrer","year":"2017","unstructured":"Ferrer A, Altabella T, Arro M, Boronat A. Emerging roles for conjugated sterols in plants. Prog Lipid Res. 2017;67:27\u201337.","journal-title":"Prog Lipid Res"},{"issue":"10","key":"4174_CR52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/antiox8100492","volume":"8","author":"N Sharma","year":"2019","unstructured":"Sharma N, Sharma A, Bhatia G, Landi M, Brestic M, Singh B, Singh J, Kaur S, Bhardwaj R. Isolation of phytochemicals from bauhinia variegata L. bark and their in vitro antioxidant and cytotoxic potential. Antioxidants (Basel). 2019;8(10):492.","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"4174_CR53","first-page":"1329","volume":"27","author":"S Li","year":"2005","unstructured":"Li S, Huang S, Peng SB. Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. Int J Oncol. 2005;27(5):1329\u201339.","journal-title":"Int J Oncol"},{"key":"4174_CR54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ceb.2014.01.005","volume":"27","author":"M O\u2019Hayre","year":"2014","unstructured":"O\u2019Hayre M, Degese MS, Gutkind JS. Novel insights into G protein and G protein-coupled receptor signaling in cancer. Curr Opin Cell Biol. 2014;27:126\u201335.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"4174_CR55","first-page":"1","volume":"2","author":"JD Frenster","year":"2020","unstructured":"Frenster JD, Kader M, Kamen S, Sun J, Chiriboga L, Serrano J, Bready D, Golub D, Ravn-Boess N, Stephan G, et al. Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypes. Neurooncol Adv. 2020;2(1):1\u20139.","journal-title":"Neurooncol Adv"},{"key":"4174_CR56","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuroscience.2014.08.015","volume":"278","author":"AE Cherry","year":"2014","unstructured":"Cherry AE, Stella N. G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues. Neuroscience. 2014;278:222\u201336.","journal-title":"Neuroscience"},{"issue":"2","key":"4174_CR57","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1215\/S1152851704001115","volume":"7","author":"B Kaur","year":"2005","unstructured":"Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol. 2005;7(2):134\u201353.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4174_CR58","doi-asserted-by":"crossref","first-page":"113451","DOI":"10.1016\/j.yexcr.2022.113451","volume":"423","author":"S Hu","year":"2022","unstructured":"Hu S, Cai J, Fang H, Chen Z, Zhang J, Cai R. RPS14 promotes the development and progression of glioma via p53 signaling pathway. Exp Cell Res. 2022;423(1):113451.","journal-title":"Exp Cell Res"},{"issue":"1","key":"4174_CR59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/CAD.0000000000000824","volume":"31","author":"T Wang","year":"2020","unstructured":"Wang T, Li X, Sun SL. EX527, a Sirt-1 inhibitor, induces apoptosis in glioma via activating the p53 signaling pathway. Anticancer Drugs. 2020;31(1):19\u201326.","journal-title":"Anticancer Drugs"},{"issue":"12","key":"4174_CR60","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.3390\/cells10123327","volume":"10","author":"Z Wang","year":"2021","unstructured":"Wang Z. Regulation of cell cycle progression by growth factor-induced cell signaling. Cells. 2021;10(12):3327.","journal-title":"Cells"},{"issue":"5","key":"4174_CR61","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland K. Cell cycle regulation: p53\u2013p21-RB signaling. Cell Death Differ. 2022;29(5):946\u201360.","journal-title":"Cell Death Differ"},{"issue":"1","key":"4174_CR62","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1096\/fj.201901629RR","volume":"34","author":"P Liu","year":"2020","unstructured":"Liu P, Zhu C, Luo J, Lan S, Su D, Wang Q, Wei Z, Cui W, Xu C, Yang X. Par6 regulates cell cycle progression through enhancement of Akt\/PI3K\/GSK-3beta signaling pathway activation in glioma. FASEB J. 2020;34(1):1481\u201396.","journal-title":"FASEB J"},{"issue":"9","key":"4174_CR63","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/cns.13688","volume":"27","author":"ZQ Zhao","year":"2021","unstructured":"Zhao ZQ, Wu XJ, Cheng YH, Zhou YF, Ma XM, Zhang J, Heng XY, Feng F. TROAP regulates cell cycle and promotes tumor progression through Wnt\/beta-Catenin signaling pathway in glioma cells. CNS Neurosci Ther. 2021;27(9):1064\u201376.","journal-title":"CNS Neurosci Ther"},{"key":"4174_CR64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-030-30651-9_4","volume":"1202","author":"D Wypych","year":"2020","unstructured":"Wypych D, Pomorski P. Calcium signaling in glioma cells: the role of nucleotide receptors. Adv Exp Med Biol. 2020;1202:67\u201386.","journal-title":"Adv Exp Med Biol"},{"issue":"23","key":"4174_CR65","doi-asserted-by":"crossref","first-page":"13173","DOI":"10.3390\/ijms222313173","volume":"22","author":"L Roger","year":"2021","unstructured":"Roger L, Tomas F, Gire V. Mechanisms and regulation of cellular senescence. Int J Mol Sci. 2021;22(23):13173.","journal-title":"Int J Mol Sci"},{"key":"4174_CR66","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2018.04.009","volume":"426","author":"K Subburayan","year":"2018","unstructured":"Subburayan K, Thayyullathil F, Pallichankandy S, Rahman A, Galadari S. Par-4-dependent p53 up-regulation plays a critical role in thymoquinone-induced cellular senescence in human malignant glioma cells. Cancer Lett. 2018;426:80\u201397.","journal-title":"Cancer Lett"},{"issue":"1","key":"4174_CR67","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijrobp.2009.08.054","volume":"76","author":"A Jinno-Oue","year":"2010","unstructured":"Jinno-Oue A, Shimizu N, Hamada N, Wada S, Tanaka A, Shinagawa M, Ohtsuki T, Mori T, Saha MN, Hoque AS, et al. Irradiation with carbon ion beams induces apoptosis, autophagy, and cellular senescence in a human glioma-derived cell line. Int J Radiat Oncol Biol Phys. 2010;76(1):229\u201341.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1\u20133","key":"4174_CR68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.schres.2011.11.002","volume":"135","author":"DE Adkins","year":"2012","unstructured":"Adkins DE, Khachane AN, McClay JL, Aberg K, Bukszar J, Sullivan PF, van den Oord EJ. SNP-based analysis of neuroactive ligand-receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: data from the CATIE study. Schizophr Res. 2012;135(1\u20133):200\u20131.","journal-title":"Schizophr Res"},{"key":"4174_CR69","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2019.01.020","volume":"698","author":"A Ozawa","year":"2019","unstructured":"Ozawa A, Kadowaki E, Horio T, Sakaue M. Acetylcholine suppresses the increase of glia fibrillary acidic protein expression via acetylcholine receptors in cAMP-induced astrocytic differentiation of rat C6 glioma cells. Neurosci Lett. 2019;698:146\u201353.","journal-title":"Neurosci Lett"},{"issue":"51","key":"4174_CR70","doi-asserted-by":"crossref","first-page":"88488","DOI":"10.18632\/oncotarget.19691","volume":"8","author":"YL Lan","year":"2017","unstructured":"Lan YL, Wang X, Xing JS, Yu ZL, Lou JC, Ma XC, Zhang B. Anti-cancer effects of dopamine in human glioma: involvement of mitochondrial apoptotic and anti-inflammatory pathways. Oncotarget. 2017;8(51):88488\u2013500.","journal-title":"Oncotarget"},{"issue":"1","key":"4174_CR71","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1471-4159.2008.05357.x","volume":"106","author":"M Tsuchioka","year":"2008","unstructured":"Tsuchioka M, Takebayashi M, Hisaoka K, Maeda N, Nakata Y. Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells. J Neurochem. 2008;106(1):244\u201357.","journal-title":"J Neurochem"},{"issue":"6","key":"4174_CR72","doi-asserted-by":"crossref","first-page":"e01951","DOI":"10.1016\/j.heliyon.2019.e01951","volume":"5","author":"L Zhang","year":"2019","unstructured":"Zhang L, Wang D, Han X, Tang F, Gao D. Mechanism of methylation and acetylation of high GDNF transcription in glioma cells: a review. Heliyon. 2019;5(6):e01951.","journal-title":"Heliyon"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04174-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-023-04174-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-023-04174-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T06:46:19Z","timestamp":1730184379000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-023-04174-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4174"],"URL":"https:\/\/doi.org\/10.1186\/s12906-023-04174-7","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"342"}}